Always Audit Ready: The New Standard for FDA-Regulated Manufacturers

The FDA's expanded use of potentially unannounced, one-day inspections signals a fundamental shift in regulatory oversight and is reshaping what "compliance readiness" means for manufacturers.

For decades, FDA inspections followed a relatively predictable rhythm. Facilities could anticipate scheduled visits, mobilize their teams, pull together documentation and present a polished compliance picture. That rhythm is now being disrupted.

In May 2026, the FDA announced it’s piloting a one-day inspectional assessments program, involving shorter, focused screening visits designed to complement standard inspections.

The pilot began in April 2026 and spans multiple FDA inspectorates, including medical products, biologics, human and animal foods, and clinical research programs. It is built around risk-based facility selection, using criteria such as product type, prior inspection history and operational characteristics.

FDA Commissioner Marty Makary noted that these reviews allow the agency to "assess more facilities and gather critical insights without compromising regulatory rigor." 

Contents

What unscheduled audits mean for manufacturers

The risks of reactive compliance

Maintaining an "always audit-ready" operational state

The operational upside of continuous audit readiness

Continuous compliance as a competitive advantage

What unscheduled audits mean for manufacturers

FDA-regulated industries should consider the FDA’s new program part of a broader, philosophical shift in quality management. As we see in several recent updates to quality standards, regulators are signaling that compliance should be a permanent operational state.

Manufacturers relying on manual, disconnected or siloed quality processes, face a distinct vulnerability. If an FDA investigator expects to see complete compliance in one day, there will be little time to gather documentation, especially if it includes locating missing records, reconstructing audit trails or finding current statuses. Either documentation is current and accessible, or it isn't.

The risks of reactive compliance

Reactive compliance is when manufacturers treat quality as something to demonstrate when required, rather than something lived every day. It shows up as last-minute document scrambles before scheduled audits, training records updated in a hurry and CAPA logs that haven't been touched in months.

If FDA inspections are predictable, reactive compliance is a manageable risk. With potentially unannounced, shorter assessments in play, it may be a liability.

Common exposure points:

• Incomplete or outdated records that can't be surfaced quickly raise immediate red flags.

• Fragmented quality data spread across systems, email threads, and binders makes it nearly impossible to demonstrate end-to-end traceability under pressure.

• Undertrained personnel who can't speak confidently to current procedures signal a systemic gap in quality culture.

• Unresolved CAPAs or change control actions become liabilities the moment an investigator starts asking questions.

Any one of these gaps can escalate a one-day assessment into a multi-day inspection or, worse, trigger a Form 483 observation or Warning Letter. 

Maintaining an "always audit-ready" operational state

The manufacturers who will weather unexpected inspections the best are those with the right systems in place. A modern Quality Management System (QMS) provides exactly that foundation.

Disconnected quality processes create gaps investigators are trained to find: A training record that doesn't link to the procedure it covers. A CAPA that was closed without documented verification. A change that was implemented before the approval workflow was complete. In isolation, each of these might seem minor. Together, they paint a picture of a quality system that isn't really a system at all.

A modern eQMS changes that by connecting every quality process in a single, unified environment.

• Documents link to training requirements.

• Training links to employee qualifications. CAPAs link to the nonconformances that triggered them and the effectiveness checks that closed them.

• Change control links to the documents and processes it affects.

In a QMS like QT9, every action is timestamped, attributed and traceable because the system captures it automatically.

That interconnectedness is what makes always audit-ready achievable. The records are always current, audit trails are intact and the team can respond to auditors with confidence because the quality system reflects how the facility actually operates every day.

Document Control

For regulated manufacturers, every standard operating procedure, work instruction and quality record must be current, version-controlled and immediately retrievable. A QMS with centralized document control ensures that approved documents are accessible in real time, revision histories are automatically maintained and obsolete versions can't be mistakenly referenced. When an investigator asks to see a specific SOP, the document is just a few clicks away and doesn't require a trip to a filing cabinet.

Training Management

Inadequate employee training is consistently cited in FDA observations. Inspectors look for documented proof that personnel have the level of training they need about current regulations and are qualified for the tasks they perform. Any gaps signal systemic quality culture problems.

An eQMS streamlines training compliance by:

• Linking training directly to roles and documents

• Automatically flagging employees when retraining is due

• Maintaining a complete training history for every individual

With an automated QMS, if an investigator asks whether your line operator is qualified to perform a given procedure, you can show documented proof on the spot.

CAPA Management

Corrective and Preventive Actions (CAPA) are a window into how seriously a facility takes quality problems. Investigators want to see documented proof of how CAPA issues are identified, investigated, resolved and verified as effective.

An eQMS provides a structured, trackable CAPA workflow with timestamps, assigned owners, root cause documentation, and closure verification, so there's never a question about whether an issue fell through the cracks.

Change Control

Uncontrolled changes to processes, equipment or materials are a frequent source of compliance findings. An eQMS enforces a formal change control process, requiring documented justification, impact assessment, approval workflows and post-implementation review before any change takes effect. The result is a clear, defensible record showing that every significant change was properly evaluated and authorized.

Audit Trails and Electronic Records

Investigators increasingly expect to see electronic records that are accurate, complete and tamper-evident. A robust QMS automatically logs every action taken on a record -- who accessed it, what was changed and when -- creating an unbroken audit trail that satisfies both 21 CFR Part 11 requirements and broader data integrity expectations. The goal is being able to prove your quality data is trustworthy.

Internal Audit Management

Organizations that conduct rigorous internal audits are less likely to be caught off guard by external ones. An eQMS supports a structured internal audit program by maintaining audit schedules, capturing findings, tracking corrective actions to closure and generating reports that demonstrate proactive quality oversight. Consistent internal auditing builds the muscle memory of being evaluated and responding effectively.

The operational upside of continuous audit readiness

The same eQMS capabilities that prepare a facility for an unannounced FDA visit also drive day-to-day operational performance.

Speed. When quality processes are automated and centralized, teams spend less time hunting for records, chasing approvals and reconciling data from multiple systems. Quality workflows move faster, and issues get resolved before they compound.

Visibility. Quality leaders and executives get real-time insight into compliance status across the organization, including open CAPAs, overdue training, pending change control items, upcoming audits. Nothing lives on someone's individual drive or on a whiteboard. Risks are visible before they become findings.

Accountability. Automated task assignments, due date tracking and escalation notifications ensure that quality responsibilities don't get lost in the day-to-day. When everyone can see their obligations and their deadlines, follow-through improves across the board.

Traceability. In the event of a product quality issue, customer complaint or regulatory inquiry, an eQMS provides end-to-end traceability from raw materials through production to distribution. This capability is invaluable, not just for inspections, but for recall management, customer audits and supplier qualification.

Continuous compliance as a competitive advantage

The FDA's new program is seen as part of a broader regulatory push to embed quality in every aspect of the manufacturing process for highly regulated industries. Manufacturers must eliminate activities that hinder preparedness, such as the use of disconnected systems and manual workarounds.

Manufacturers who will lead in this environment are those who have embedded compliance into how they operate every day. Modern quality management software, like QT9 QMS, makes that possible by automating workflows and record maintenance and providing the real-time visibility that transforms compliance into a continuous operational standard.

QT9 QMS is a cloud-based quality management software platform designed to help regulated manufacturers centralize and automate their quality processes, from document control and training to CAPAs, change control and audit management. To learn how QT9 QMS supports continuous compliance readiness, request a demo today.